Filana Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Filana Therapeutics, Inc. (FLNA) had Operating Leases, Future Minimum Payments, Due in Two Years of $99.00 thousand as of 2019-09-30, per its 10-Q filed 2019-10-29.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-10-29
- 2019-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $99.00K.
- 2019-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $99.00K.
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $99.00K.
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $95.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2019-09-30 | $99.00K 10-Q · filed 2019-10-29 |
| 2019-06-30 | $99.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $99.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $95.00K 10-K · filed 2019-03-29 |
| 2018-09-30 | $95.00K 10-Q · filed 2018-10-30 |
| 2018-06-30 | $95.00K 10-Q · filed 2018-07-26 |
| 2018-03-31 | $95.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $95.00K 10-K · filed 2018-02-06 |
| 2016-09-30 | $147.00K 10-Q · filed 2016-10-26 |
| 2016-06-30 | $146.00K 10-Q · filed 2016-07-19 |
| 2016-03-31 | $146.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $146.00K 10-K · filed 2016-03-03 |
| 2015-09-30 | $146.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $146.00K 10-Q · filed 2015-07-23 |
| 2015-03-31 | $146.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $146.00K 10-K · filed 2015-02-18 |
| 2014-09-30 | $143.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $143.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $178.00K 10-Q · filed 2014-05-07 |
| 2013-09-30 | $81.00K 10-Q · filed 2013-11-01 |
| 2013-06-30 | $81.00K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $81.00K 10-Q · filed 2013-04-24 |
| 2012-12-31 | $81.00K 10-K · filed 2013-02-08 |
| 2011-12-31 | $81.00K 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |